INBX - CIK 0001739614
Inhibrx, Inc. (INBX) reported net income of -$241.36M for fiscal year 2023, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2023 | -$241.36M | -66.2% |
| FY 2022 | -$145.23M | -77.6% |
| FY 2021 | -$81.77M | -7.4% |
| FY 2020 | -$76.12M | -48.1% |
| FY 2019 | -$51.40M | - |
Inhibrx, Inc. (INBX) reported net income of -$241.36M for fiscal year 2023, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2023, Inhibrx, Inc.'s net income declined from -$51.40M to -$241.36M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.